Foto von Hanfblatt vor Sonnenuntergang

Expertise in Committee – An Overview

Today the Health Committee is meeting on the CanG and hearing the statements of experts from science, business, the judiciary and civil society. We have evaluated the positions and provide an overview.

More than 30 individual expert opinions were submitted to the committee. Many of the positions are well known. While, among others, the Richterbund (German Association of Judges), the Deutsche Polizeigewerkschaft (German Police Union) and the Berufsverband der Kinder- und Jugendärzte (Professional Association of Pediatricians) firmly reject the project, the planned legalization does not go far enough for the Deutscher Hanfverband (German Hemp Association), the Grüne Hilfe, the umbrella organization of Cannabis Social Clubs and also the Republikanischer Anwaltsverein (Republican Lawyers’ Association).

More approval than rejection
Calls for prevention

Reservations on health, legal or financial grounds are voiced by, among others, the Spitzenverband der Gesetzlichen Krankenkassen (National Association of Statutory Health Insurance Funds) and the Gewerkschaft der Polizei (Police Union).

In principle, many experts welcome the paradigm shift in German drug policy and see real opportunities for a more conscious approach to cannabis and other drugs, above all in decriminalization and destigmatization. These include the Bundesverband für akzeptierende Drogenarbeit (Federal Association for Acceptance-Oriented Drug Work) and the Deutsche Gesellschaft für Psychiatrie (German Association for Psychiatry).

A recurring point of criticism is the insufficient funding of counseling and treatment centers for education, prevention and therapy. Almost regardless of the position on legalization, a great need to catch up is seen here.

Summary of the individual expert contributions

states that cannabis is not harmless and poses a danger to mental health. The risks of dependence, in particular of physical dependence, are emphasized. However, in the chamber’s view it is necessary to realign drug policy, since prohibition to date has failed. In addition, it says, the CanG does not go far enough to achieve destigmatization, prevention, and access to and availability of support services:

“It is questionable to what extent the exemption for possession without penalty and the legal distribution of cannabis can, on their own, also bring about to a significant degree the necessary destigmatization of cannabis use, so that addiction prevention measures take greater effect and, in particular, consumers with problematic cannabis use or cannabis dependence seek support at an earlier stage.”

welcomes the legislative initiative in principle and sees the CanG as a major step for Germany and toward decriminalization and an end to discrimination against consumers. However, in the industry association’s opinion it is necessary to include the industry in a full legalization, since otherwise it would not be possible to push back the black market and the potential of the cannabis industry – including with regard to industrial hemp and medical cannabis – would not be fully tapped. Legal certainty for clubs, consumers, patients, doctors, pharmacists and the cannabis industry is also said to be insufficient:

“For consumers, the draft bill appears to be more of a prohibition law with exceptions, since when consuming in public they can never be sure that they are, for example, complying with distance rules. For patients there are many improvements, but the problem of the high rejection rate remains. Doctors, pharmacists and the cannabis industry continue to face a very complex legal situation, since although there is talk of a changed risk assessment, large parts of the Narcotics Act were simply adopted.”

provide a statement focusing on punishment, law and legal systematics. They also call for “daring less criminal law.” In their remarks they additionally address spurious arguments and “smokescreens” of the “opponents of legalization.” Criticism that decriminalization would fail to relieve the justice system does not, they argue, justify “clinging to the status quo.” Instead, consumption-related conduct should even be downgraded to an administrative offense. An alleged abuse of the cultivation associations is likewise said to be beside the point, since without legalization cannabis would continue to be obtained exclusively via the black market, and organized crime is unlikely to file permit applications. Finally, they say, there is also insufficient evidence that a 25 g exemption limit would undermine the protection of minors and additionally encourage more consumption. After all, even with criminal liability under the BtMG, consumption has risen in recent years, and the experience from Canada shows that there was no “breach of the dam” with a rise in consumption.

“The CanG will perhaps not solve the problem of harmful cannabis use, which exists today and always will, but it is an important step toward an evidence-based drug policy that concentrates on regulating the dangers of consumption instead of enlarging the problem through criminal prosecution”

The professional association rejects the release of cannabis in the form of the draft bill. The legalization plans would, it says, endanger the mental health and the development opportunities of young people in Germany. Moreover, the measures provided for are said to be in no way sufficient to dispel concerns about the danger to the health of children and adolescents. A cannabis reform should place prevention (“Education, Enforcement, Economy, Engineering and Evaluation”) and not release at its center.

“The harmful effects of early-onset and regular cannabis use among adolescents and young adults are medically well known. Truly effective protection of minors is therefore needed. The deplorable increase in cannabis use among German adolescents in recent years shows that the existing measures and prevention services are not sufficient.”

cannot make out any real legalization in the draft so far, but expressly welcomes the general direction the law is taking. Equally welcomed is a readjustment of the range of penalties following the downgrading of cannabis in comparison with other drugs. The legal opening of access to “therapy instead of punishment” and the intended deletion of entries in the central criminal register also convince the bar association.

“After all, in a liberal state governed by the rule of law, the “sharp sword” of criminal law should be used only as a last resort and only when the protection of legal interests can no longer be ensured in any other way. Where doubts arise about the benefit of criminalization, the legislature is well advised to opt for a withdrawal of criminal law, because the socio-ethical judgment of reprehensibility that is already attached to the abstract threat of punishment in itself constitutes a serious interference with the general freedom of action and is therefore subject to a particular burden of justification.”

welcomes the draft bill as protection for consumers through the quality control of consumer cannabis, the prevention of the distribution of contaminated substances and the strengthening of cannabis-related education and prevention. The DKFZ emphatically points to the proven carcinogenic dangers of mixed consumption with tobacco and calls for an increase in the tobacco tax as well as stronger protection of non-smokers.

“Smoking cannabis is thus the most widespread form of cannabis use in Germany – even among people who do not smoke. At the same time, it is the most harmful way of consuming cannabis. Nevertheless, cannabis smoking is not mentioned at all in the current draft bill. From the DKFZ’s point of view, this is problematic for several reasons”

welcomes the draft’s aim of a regulated release of cannabis for adults. Continued criminalization can no longer be justified, it says, since cannabis is widespread despite prohibition. The NRV does see proven health risks from consumption in adolescence, but recognizes a lower risk for adults. In addition, it calls for improvements to the provisions on the legal term “not small quantity,” on contradictions between “cultivation, production and possession,” and on the recognizability of and justification for the 200 m distance in “exclusion zones.”

“These highlights show a fundamental need to revise the conception of the Act on the Controlled Handling of Cannabis and on the Amendment of Further Provisions. It is for the democratically legitimized legislature to adapt criminal provisions to developments in society, as the Federal Constitutional Court emphasized only recently (BeckRS 2023, 16492 para. 93). To do justice to this task, it must, if only in view of Art. 103 (2) of the Basic Law (GG), present a systemically coherent law geared to a concise protective purpose.”

limits its statement to the supply of cannabis for medical and medical-scientific purposes (MedCanG) and sees inconsistent administrative practice and, in part, contradictory case law in the handling of medical cannabis. Accordingly, it says, medical use should be made easier, also in order to strengthen Germany as a location for research and business:

“For the import and export of narcotics, an extension of the permit under Section 3 of the Narcotics Act (BtMG) currently has to be applied for at the BfArM for every single product. This takes about 2–3 months and is a disadvantage compared with other EU member states when it comes to imports. The current procedure is time-consuming and costly and places an immense burden on the BfArM, scientific research institutions and cannabis companies. To do justice to the changed risk assessment of cannabis, the bureaucratic effort involved in import and export should be reduced. There is no discernible rationale for this procedure, since the annual report to the United Nations asks only for the quantity of cannabis and not for specific products.”

welcomes the draft bill’s intention of facilitating a responsible approach to cannabis and sees it as an important step toward a better drug and health policy. Among the things it endorses are information, counseling and prevention services, the reduction of risks for consumers, environmentally friendly and sustainable home cultivation, and the appointment and training of prevention officers in cultivation associations. It rejects the ban on consumption in social clubs, the objections of the opposition parliamentary groups and their amendment motions. Beyond that, it says, legalization must not end with cannabis:

“The decriminalization of cannabis possession and acquisition through this new law is an important step, but one that must be followed by others, because there are still hundreds of thousands of people in Germany who consume other, still illegal substances such as heroin, cocaine, crack or other psychoactive substances and therefore have to expect long prison sentences, which can reduce neither the consumption of nor the dependence on these substances and which make the medical, psychiatric and psychotherapeutic treatment that is often necessary more difficult or impossible. Here the good experience from Portugal should be used to stop this criminalization!”

expressly welcomes the core of the law. It would, he says, mean the end of decades of pointless prosecution as well as the avoidance of unnecessary, costly criminal proceedings. This would also eliminate injustice caused by the pressure of prosecution and strengthen trust in the state. On the other hand, there are also points of criticism: the “possession quantities” are too low, the “criminal offenses” are disproportionately severe, “fines” leave room for arbitrariness, the sale of “cannabis seeds” should be permitted, “cultivation associations” would be regulated too heavily, “protection of minors” gets short shrift, “distance rules” are unrealistic in cities and “pillar 2” should follow without fail. Werse rejects the CDU/CSU’s fundamental criticism of legalization:

“The counter-motion of the CDU/CSU parliamentary group is to be rejected from a scientific point of view because, for one thing, it relies on the same means of prohibition and criminal law that for decades have not come close to achieving their goals. For another, it proceeds from false or at least heavily distorted premises. The concluding recommendations of the CDU/CSU parliamentary group seem like a déjà vu of decades of failed drug policy: all the means that have not worked for a long time are offered here once again as supposed solutions.”

firmly and entirely rejects the draft bill. In particular, the points on consumption, exemption limits, home cultivation, collective cultivation and distribution are rejected, since in any form they are said to be harmful to health and to the protection of children and adolescents. Against the backdrop of already overburdened medical care systems, the mental health and the future of the “young generation in Germany” would, it says, be put at risk.

“The stated goals of the draft bill are not achieved by the provisions envisaged. Rather, the prevalence of cannabis use and cannabis-related health and social problems will continue to increase. It is not a realistic expectation that the particularly vulnerable group of children and adolescents could be effectively protected from access to cannabis that is spread through private and non-commercial, collective home cultivation, and from the black market that, according to international experience, is still to be expected. The draft bill’s provisions on health protection and the protection of children and minors as well as on preventive measures will merely lead to a considerable monitoring burden for the authorities, which are overburdened as it is.”

regrets that previous proposals and statements have not found their way into the draft bills, but sees the CanG as heading in a good direction and hopes for relief in the supply of medical cannabis. The legal separation between cannabis for medical purposes and recreational cannabis is said to be especially important. It supports dispensing being reserved for pharmacies. It calls for a national funding program for education and research, a competence center for cannabis and the abolition of the health insurers’ prior-approval requirement. In addition, patients should not be covered by consumption bans:

“The legalization of cannabis must not lead to a deterioration in the care of chronically and seriously ill patients. This also includes the possibility of taking cannabis as medication in public spaces.”

sees many points of criticism and concerns as not dispelled by the draft so far. In principle the ACM welcomes the separation between recreational and medical use, but criticizes the continuing stigmatization of patients and a dismissive attitude on the part of the health insurers. This, it says, would mean that patients would still not be cared for by the health system in future and would turn to the recreational market. At least they would have legal access there and criminal prosecution would be lifted. In many other places, however, the association sees a fundamental need for improvement:

“During the debate in the German Bundestag it became clear that specialist politicians of the governing parliamentary groups, too, would like to see improvements, which the ACM welcomes in principle and which could improve the law’s practicability and thus also the achievement of its goals. This concerns, for example, the planned distance rules between cultivation associations and schools and kindergartens, upper limits for the possession of cannabis, or restrictions on consumption in public, which also affect patients.”

holds firmly to a separation between medicine and recreational use and demands that medical treatment and care take unconditional precedence in the event of illness. The BPI also welcomes the advertising ban for cultivation associations and the consumption bans for the protection of children and minors, but would like exceptions for medical products. It also supports a strengthening of research and science. In the rules on road traffic, it says, more legal certainty is needed, and the protection of children and minors is insufficient:

“In our view it cannot be ruled out that patients who until now have had to pay for their therapy themselves at the pharmacy because of a rejection notice from their health insurer might, after legalization, turn to cannabis from the consumer market, which can have very considerable health consequences and effects. They could thus be removed from a sensibly adjusted therapy, or this “low-threshold offer” on the consumer market can thwart an existing medical therapy. In the context of prevention, too, the needs and developments of these patients absolutely must be taken into account.”

points to its own decades of commitment and support work for victims of disproportionate criminal prosecution and welcomes the governing coalition’s “decriminalization efforts,” although these are said to still fall short.

“The influence of drug policy on the population’s intoxication behavior is small, if measurable at all. The criminalization of cannabis causes measurable harm to those affected without having any benefit or even achieving an “improvement of conditions.” For this reason alone we consider it more than overdue to lift the ban quickly and without fuss.”

is scathing about the draft bill and voices considerable concerns about the planned legalization. In particular, the assumption that the justice system would be relieved is rejected as “inaccurate,” since numerous criminal offenses, for instance concerning trafficking and import, would continue to exist, making elaborate investigations and criminal proceedings necessary “while at the same time considerably restricting” the investigative options of law enforcement authorities. Likewise, it says, there will be “abuse of cultivation associations” and a very considerable strengthening of the black market. An improvement in health protection and the protection of minors is also said to be more than questionable:

“It can already be stated now, however, that the protection of children and minors will not be improved by the Cannabis Act but weakened, because the range of penalties, reduced in future, for (commercial) distribution of cannabis to minors or children will have less of a deterrent effect on dealers. At the same time, it is to be expected that the absence of state sanctions will lead to greatly increased consumption of cannabis by adolescents.”

defends a clear separation between recreational and medical use in order to “protect patients who genuinely need treatment from being discredited by pseudo-prescriptions for medication abuse.” The BDCan sees this as the reason for the restrictive treatment of medical cannabis and hopes for relief in prescribing and reimbursement as well as further demarcation through advertising bans and a labeling requirement for recreational use, so that as far as possible no patients drift into the recreational sphere or have to fall back on it:

“This goal becomes all the more urgent given the government’s plan to legalize recreational cannabis, since with today’s high hurdles for the supply of medical cannabis a large outflow of patients into medically unsupervised self-medication with recreational cannabis is to be expected, as was also observed after the liberalizations in Canada, the Netherlands and other countries”

credits the legislation with a realistic recognition of social reality. Consumption figures have been rising for many years, even and in spite of bans. He criticizes the CDU/CSU’s truncated presentation of scientific research and puts forward the proposal of a limited commercialization with a “state monopoly in combination with cultivation clubs.” Manthey also considers the expansion of addiction support, medical care, scientific research and monitoring to be indispensable

“Against the backdrop of rising consumption and treatment figures, a liberalization of cannabis legislation may appear contraindicated. Out of concern about a rise in consumption and the problems associated with it, the CDU/CSU parliamentary group in the Bundestag cites a study according to which legalization for adults would lead to an expansion of consumption. In fact, this study, which I led, paints a considerably more nuanced picture. According to the current state of knowledge, a rise in consumption as a result of legalization is attributable not to a reduction in criminal liability but to commercialization.”

sees positive approaches to decriminalization and the attempt to reduce the illegal market and to permit cannabis products without contaminants or additives in a controlled setting and under rules. It is emphasized that cannabis would not be offered on a profit-oriented “free market,” whereby negative consequences such as the control of THC content, pricing and thus also the extent of an illegal market would be contained. It criticizes insufficient prevention through central services of the BZgA (Federal Centre for Health Education). In addition, an increase in hospitalizations and an overburdening and growing underfunding of the addiction support system would have to be expected.

“Additional care for people with cannabis-related disorders should lead to the outpatient and inpatient support system being promoted or stabilized (for instance through guaranteed funding of addiction counseling centers) or through a financial and administrative (bureaucracy) improvement in the position of outpatient or inpatient addiction-medicine and psychiatric care. Unfortunately, no funds or stipulations for therapy or for research in these areas are to be found in the law.”

welcomes the objective of protecting children and minors and sees a paradigm shift with goal-oriented prevention for educational support and for enabling competent consumption. It also welcomes prevention officers in associations, the ban on advertising and sponsorship, the extension of non-smoker protection, the expansion of drug checking, the ban on consumption in the presence of minors and the ban on edibles. It criticizes the lack of practicability of protection and exclusion zones, ambiguities in early intervention and the lack of oversight of private cultivation. In addition, the emergence of a “gray market” is feared. But overall, it says, the CanG would not worsen the protection of children and minors.

“The paradigm shift associated with the change in the legal basis – previously prohibited for everyone, then permitted for adults – must be taken up and funded in prevention through the (further) development of cannabis prevention services. We demand that services of educational child and youth protection be enshrined in law as part of cannabis prevention. In doing so, services should be developed and expanded not only for young people but also for their parents and other legal guardians, in order to strengthen their parenting skills in view of the new legal situation”

refers in its statement exclusively to the planned changes to the MedCanG and asks for explicit and legally secure solutions for companies’ existing permit arrangements. Moreover, it says, it appears unclear how stocks are to be handled, since they were still built up under the legal regime of the BtMG. It hopes for improvements with regard to exemptions from permit requirements and relief for import and export:

“PHAGRO therefore asks for clarification that in the cases mentioned above the requirement of a permit under Section 3 BtMG for foreign trade in cannabis no longer applies; otherwise wholesalers would need, for foreign trade in cannabis for medical purposes, a permit pursuant to Section 52a AMG (Medicinal Products Act), pursuant to Section 4 MedCanG, pursuant to Section 12 MedCanG and pursuant to Section 3 BtMG. We further urgently ask that the necessity, expediency and proportionality of the permit system be examined with regard to full-line pharmaceutical wholesalers and their mandate to ensure supply pursuant to Section 52b (2) sentence 2 AMG, which is tied to obtaining the permit and which also covers cannabis for medical purposes.”

abstains on the question of the political assessment of legal access to cannabis for non-medical use. Nevertheless, it questions whether far-reaching relaxations of the restrictions are suited to curbing the consumption of cannabis, or whether these relaxations might not even bring about an expansion of cannabis use. Prevention and the protection of children and adolescents should, it says, receive more attention, and the follow-on costs of negative consequences would place an additional burden not only on those affected but also on contributors:

“Long-term cannabis use carries a risk of dependence and is closely associated in scientific research with anxiety disorders, depression, schizophrenia, visual and speech disorders, tachycardia and other illnesses. Furthermore, changes in brain function that can lead to an impairment of cognitive abilities are discussed as a consequence of long-term cannabis use. Added to this is the mixed consumption with tobacco that is common in Germany, with its well-known long-term consequences for health.”

welcomes the legislative initiative of the CanG and calls for clear improvements for medical production as well as commercial implementation through pillar 2 measures. For this it would be necessary to create fair conditions for producers, to increase the cultivation volume in Germany and to introduce a simplified permit system. In addition, he says, a clear timetable for commercial supply chains and pilot projects should be presented.

“The production of medical cannabis in Germany contributes significantly to the high-quality care of patients. Because of the structural disadvantage compared with imports, however, Germany as a production location is under threat. The CanG now offers the opportunity to improve the conditions for medical cannabis production “Made in Germany.” Companies such as DEMECAN stand ready to meet the growing medical demand for cannabis.”

voices considerable doubts about the expectations for the planned law and points out that cannabis use among children and adolescents is “always associated with considerable and irreversible harm.” It also criticizes Federal Health Minister Karl Lauterbach for “pushing through” the law. The DPolG is also able to detect “satirical components” with regard to the compliance costs and points to a lack of staff resources for implementation as well as several imprecisions in the monitoring rules for cultivation, distribution and consumption. The loss of prevention through the removal of penalties is also criticized.

“The Bundesrat criticizes the low ranges of penalties, which are not consistent with the central objective of the draft bill of strengthening the protection of children, minors and health and pushing back the illegal black market. The Deutsche Polizeigewerkschaft (DPolG) fully endorses this criticism. It is incomprehensible why, for example, the possession of cannabis should be exempt from punishment for adolescents even when it was obtained on the black market. The latter will regularly be the case, since adolescents are excluded from acquiring it in the cultivation facilities.”

sees the paradigm shift in German cannabis policy as a major task for society, which, however, must not lead to security of care being jeopardized by underfunding of the support system. The decriminalization of consumers and the necessary dismantling of restrictions on participation are assessed as fundamentally positive. The approaches to addiction prevention, early intervention and cooperation with addiction support services are also to be assessed positively, it says. It criticizes shortcomings in non-smoker protection, illegal parallel structures and a looming overload due to the need for information and counseling:

“The law must not disregard the care of people with consumption and addiction problems and absolutely must take into account the existing structures of the services and benefits of addiction support. This means that adequate and sustainably secured funding must be ensured for the local services of addiction counseling, early intervention and prevention, in order to be able to meet the existing and probably rising demand for these services.”

criticizes the draft bill and raises several objections. The age limit of 18 is said to be set too low, since cannabis use should not take place before brain maturation is complete. The distribution quantity for young adults (18–21 years) is assessed as too high. Legalization must, it says, go hand in hand with an expansion and the funding of specific counseling and support services. In addition, the funds for a scientific evaluation are said to be set too low.

“Cannabis use carries considerable health risks, especially for young people. Decriminalization must therefore include comprehensive measures in the areas of prevention and treatment, protection of minors and accompanying research. Overall, the DGPPN comes to the assessment that the measures formulated in this regard in the draft bill are far from sufficient. As long as these aspects are not adequately addressed, it will have to be feared that the law may lead to a deterioration in the health of adolescents.”

welcomes in principle the intention to transfer cannabis for medical and scientific purposes into a separate Medical Cannabis Act (MedCanG) as part of the changes planned through the Cannabis Act (CanG). It warns against a complete blockade by the opposition, since this would also have negative effects on the rules for medical cannabis. Overall, the BPC sees “immense hurdles” in the care of patients and calls for the destigmatization of medical patients through exemptions from minimum distances and consumption bans, as well as legal certainty and clear rules on the classification of cannabis as a medicinal product. In addition, licensing procedures should be made easier and research promoted.

“We therefore ask the legislature to become aware of the significance of this debate for seriously ill patients and not to jeopardize Germany’s pioneering role. On the basis of the experience gathered with the legislation to date, we see an urgent need to prioritize and take into account the concerns of cannabis patients and a secure supply.”

rejects the planned law, citing insufficient protection of children and minors. Even the public debate is said to have had unfavorable effects on young people’s consumption behavior. Addiction prevention cannot work alongside a market expansion for addictive substances, it says, and protection of minors in combination with legalization would be an illusion. The ongoing brain development of young adults also speaks against a release from a neurobiological point of view.

In summary, it can be stated that, from the DGKJP’s point of view, legalization and the market expansion for cannabis products for so-called “recreational use” send the wrong signal for addiction prevention. The changes in drug policy contribute significantly to the trivialization of the health dangers, negative consequences and long-term effects of cannabis use on the age-appropriate physical and mental development of children and adolescents.

hopes for more practical relevance in the further legislative process and criticizes false hopes regarding a reduced workload for law enforcement as well as gray areas and imprecisions in the legal terminology. In addition, a lack of legal certainty due to too short a transition between the BtMG and the CanG is feared, and possible stimulating effects on the black market are suspected. The open rules on road traffic and the insufficient funding of prevention services also fail to convince the GDP.

“If resources and time are lacking, there will be considerable uncertainty on all sides in implementing the new law. In the worst case, a real phase of chaos is to be feared, which will be attributable to the planned statutory cannabis provisions being brought into force too quickly. Such a phase of chaos risks damaging acceptance of the new legal situation.”

rejects the release of cannabis for recreational purposes on professional grounds and follows the assessment of the Arzneimittelkommission (Drug Commission). Experience to date from countries that have legalized would indicate, it says, that the prevalence of cannabis use disorders will increase.

“Cannabis reduces attention, impairs psychomotor function and induces apathy; the risk of workplace and traffic accidents rises. Moreover, in people with a genetic predisposition even a single use can trigger a psychosis; the risk of mental disorders is likewise increased. Besides an early start to cannabis use in adolescence, intensive patterns of use and co-use of tobacco are considered particular risk factors. Accordingly, more emergency and addiction treatments, traffic accidents and incapacity for work are to be feared as a consequence of a release.”

calls for noticeable improvements in order to achieve goals such as curbing the black market while at the same time strengthening the protection of minors. The CSCD refers to its alternative draft bill to the CanG and focuses its remarks on three aspects on which the law threatens to fail even before its promulgation:

“The collection of CSC members’ personal data by the authorities is a data protection nightmare. The government draft creates an unprecedented statutory stigmatization of the users of a recreational stimulant. The upper limit on possession within the enclosed property one lives in oneself (e.g. one’s own apartment, house and garden) must be adapted to the real-life circumstances of cannabis self-supply. Cannabis Social Clubs are not mere distribution points. As associations they are places of social togetherness. It is precisely the communal living and experiencing of cannabis culture that makes CSCs valuable in terms of health policy, among other things because experienced consumers can pass on their expertise and thus contribute to harm reduction.”

welcomes the draft in principle and formulates 6 top points where change is most needed: home cultivation and number of plants, distance rule for consumption & consumption in cultivation clubs, distance rules for the cultivation clubs, completely excessive threat of punishment for minor offenses, passing on to adults, equal treatment of THC and alcohol in road traffic. In addition, it calls for comprehensive improvements to the rules for CSCs/cultivation clubs. Many of the rules are said to be unnecessary and would fundamentally call into question the operation and acceptance of the clubs. In addition, it says, there are still too many open points in the draft to live up to the claim of an appropriate legalization:

“The CanG cannot replace the originally planned full regulation of the market with specialist cannabis shops throughout Germany. Home cultivation and the cultivation clubs will be able to cover only part of the demand even with optimal statutory regulation. Only with specialist shops can the black market really be reduced considerably and lastingly. In this respect we hope that at least the pilot projects for full regulation from cultivation to the specialist shop can still get under way in some regions during this legislative period.”

describes decriminalization as overdue and the CanG as an important, if only first, step in the right direction. Subsequently, it says, the second step of commercial pilot projects must also follow. The construction of the CanG in comparison with alcohol is regarded as absurd, and the reference to a “European cultural sphere” of alcohol consumption is said to leave one stunned. The CDU/CSU’s motion is said to be puzzling, with questionable assumptions about increased consumption and legalization. The RAV welcomes relief for the justice system as well as the end of the pressure of checks and the prosecution of consumers. It criticizes problems of legal systematics regarding possession, acquisition and consumption. A renewed prohibition through the “back door” is, however, said to be legally impossible:

“If the requirements are met, however, applicants have a legal entitlement to the granting of the permit (Sections 11, 12; cf. also BT‐Drs. 20/8704 p. 183 and 20/8763 p. 8). Sections 12 (3) and 13 (4) likewise offer the competent authorities no leeway to “take action against the law.” In future it will have to be strictly monitored that federal law takes precedence over state law (Art. 31 GG) and that the principle of federal loyalty is observed.”

Image sources